Diagnostic Utility of Hematological and Lipid Biomarkers in Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma
摘要
Oral squamous cell carcinoma (OSCC) often arises from oral potentially malignant disorders (OPMDs), necessitating early diagnosis and treatment. The combined diagnostic value of hematological and lipid parameters in OPMD and OSCC remains unclear.
ObjectiveTo evaluate and compare hematological and lipid parameters in OPMD and OSCC and to assess their diagnostic utility.
MethodsA cross-sectional study included 750 participants, categorized as healthy controls (n = 250), OPMD (n = 250), and OSCC (n = 250). Hematological indices (RBC, WBC, and platelets) and serum lipid metrics were analyzed using appropriate statistical tests.
ResultsRBC count, MCHC, lymphocytes, atypical lymphocytes, platelet count, and HDL decreased, whereas Hb, HCT, MCV, RDW, NRBC, neutrophils, eosinophils, NLR, MPV, PDW-SD, PCT, PLCR, TC, TG, LDL, VLDL, and Non-HDL increased in OPMD and OSCC vs. controls. NRBC, neutrophils, lymphocytes, NLR, and HDL distinguished OPMD from OSCC. Non-HDL showed the highest predictive value (AUC = 0.841). NLR, MPV, HDL, and PDW-SD also significantly differentiated OPMD from OSCC.
ConclusionHematological and lipid alterations in OPMD and OSCC reflect systemic dysregulation in oral carcinogenesis. Non-HDL showed the highest discriminative potential, while NLR, MPV, HDL, and PDW-SD modestly distinguished OPMD from OSCC. These findings warrant further validation before clinical application.